XML 15 R5.htm IDEA: XBRL DOCUMENT v3.21.4
Unaudited Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Nov. 27, 2021
Nov. 28, 2020
Nov. 27, 2021
Nov. 28, 2020
Operating activities:        
Net income (loss) $ 4,122 $ 689 $ 6,757 $ (458)
Adjustments to reconcile net income (loss) to cash provided by (used in) operating activities:        
Depreciation and amortization 859 873 1,688 1,746
Inventory provisions 57 215 140 452
Share-based compensation expense 153 178 372 379
Loss on disposal of assets 2   2  
Deferred income taxes (23) (55) 12 (53)
Change in assets and liabilities:        
Accounts receivable 1,862 687 (3,146) (167)
Inventories (4,225) 613 (9,182) (1,008)
Prepaid expenses and other assets (994) (381) (1,056) (272)
Accounts payable 1,695 211 2,302 (2,523)
Accrued liabilities 1,032 1,633 1,512 3,412
Other 91 (236) 357 (438)
Net cash provided by (used in) operating activities 4,631 4,427 (242) 1,070
Investing activities:        
Capital expenditures (770) (562) (1,607) (1,280)
Proceeds from maturity of investments       16,000
Purchases of investments       (9,000)
Net cash (used in) provided by investing activities (770) (562) (1,607) 5,720
Financing activities:        
Proceeds from issuance of common stock 672   724  
Cash dividends paid (792) (780) (1,578) (1,560)
Payment of financing lease principal (46) (46) (91) (91)
Net cash used in financing activities (166) (826) (945) (1,651)
Effect of exchange rate changes on cash and cash equivalents (448) 489 (857) 1,349
Increase (decrease) in cash and cash equivalents 3,247 3,528 (3,651) 6,488
Cash and cash equivalents at beginning of period 36,418 33,495 43,316 30,535
Cash and cash equivalents at end of period $ 39,665 $ 37,023 $ 39,665 $ 37,023